These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 12879470

  • 1. The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.
    Iavarone M, Lampertico P, Seletti C, Francesca Donato M, Ronchi G, del Ninno E, Colombo M.
    Cancer; 2003 Aug 01; 98(3):529-34. PubMed ID: 12879470
    [Abstract] [Full Text] [Related]

  • 2. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
    Kim MY, Park E, Park JH, Park DH, Moon WS, Cho BH, Shin HS, Kim DG.
    Oncogene; 2001 Jul 27; 20(33):4568-75. PubMed ID: 11494152
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K, Pal NS, Arora SK.
    Indian J Pathol Microbiol; 2006 Jul 27; 49(3):357-61. PubMed ID: 17001884
    [Abstract] [Full Text] [Related]

  • 4. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S.
    J Med Virol; 2003 Dec 27; 71(4):492-8. PubMed ID: 14556260
    [Abstract] [Full Text] [Related]

  • 5. Variation of hepatitis C virus load, hypervariable region 1 quasispecies and CD81 hepatocyte expression in hepatocellular carcinoma and adjacent non-cancerous liver.
    Young KC, Lin PW, Hsiao WC, Chang TT, Chang YC, Wu HL.
    J Med Virol; 2002 Oct 27; 68(2):188-96. PubMed ID: 12210407
    [Abstract] [Full Text] [Related]

  • 6. Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease.
    Villa E, Dugani A, Moles A, Camellini L, Grottola A, Buttafoco P, Merighi A, Ferretti I, Esposito P, Miglioli L, Bagni A, Troisi R, De Hemptinne B, Praet M, Callea F, Manenti F.
    Hepatology; 1998 Apr 27; 27(4):983-8. PubMed ID: 9537437
    [Abstract] [Full Text] [Related]

  • 7. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S.
    J Viral Hepat; 2005 Nov 27; 12(6):635-41. PubMed ID: 16255765
    [Abstract] [Full Text] [Related]

  • 8. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR, Bahnassy AA, Abdel-Wahab SA, Khafagy MM, Loutfy SA, Radwan H, Shaarawy SM.
    J Gastroenterol Hepatol; 2009 Mar 27; 24(3):416-28. PubMed ID: 19054267
    [Abstract] [Full Text] [Related]

  • 9. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
    Tanaka T, Inoue K, Hayashi Y, Abe A, Tsukiyama-Kohara K, Nuriya H, Aoki Y, Kawaguchi R, Kubota K, Yoshiba M, Koike M, Tanaka S, Kohara M.
    J Med Virol; 2004 Feb 27; 72(2):223-9. PubMed ID: 14695663
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A, Nishiguchi S, Shiomi S, Hayashi T, Kobayashi S, Habu D, Takeda T, Seki S, Hirohashi K, Tanaka H, Kubo S.
    Am J Gastroenterol; 2005 Aug 27; 100(8):1748-53. PubMed ID: 16086711
    [Abstract] [Full Text] [Related]

  • 11. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May 27; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study.
    Obika M, Shinji T, Fujioka S, Terada R, Ryuko H, Lwin AA, Shiraha H, Koide N.
    Intervirology; 2008 May 27; 51(1):59-68. PubMed ID: 18349544
    [Abstract] [Full Text] [Related]

  • 13. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N, Srinivasan R, Chawla Y, Sharma S, Chakraborti A, Rajwanshi A.
    Liver Int; 2009 Sep 27; 29(8):1162-70. PubMed ID: 19627485
    [Abstract] [Full Text] [Related]

  • 14. Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.
    De Mitri MS, Cassini R, Morsica G, Bagaglio S, Andreone P, Loggi E, Muratori P, Bernardi M.
    J Viral Hepat; 2006 Sep 27; 13(9):574-81. PubMed ID: 16907843
    [Abstract] [Full Text] [Related]

  • 15. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG, Mathews S, Jayanthi V, Shankar EM, Hari R, Surendran R, Vengatesan A, Raghuram K, Rajasambandam P, Murali A, Srinivas U, Palaniswamy KR, Pugazhendhi T, Thyagarajan SP.
    Int J Infect Dis; 2008 Nov 27; 12(6):e71-6. PubMed ID: 18658001
    [Abstract] [Full Text] [Related]

  • 16. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM, Shrestha S, Shrestha A, Tsuda F, Endo K, Takahashi M, Okamoto H.
    J Gastroenterol Hepatol; 2007 Nov 27; 22(11):1921-8. PubMed ID: 17914971
    [Abstract] [Full Text] [Related]

  • 17. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    Bortolami M, Kotsafti A, Cardin R, Farinati F.
    J Viral Hepat; 2008 Jul 27; 15(7):515-22. PubMed ID: 18331250
    [Abstract] [Full Text] [Related]

  • 18. The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C.
    Shintani Y, Yotsuyanagi H, Moriya K, Fujie H, Tsutsumi T, Takayama T, Makuuchi M, Kimura S, Koike K.
    Cancer; 2000 Jun 01; 88(11):2478-86. PubMed ID: 10861423
    [Abstract] [Full Text] [Related]

  • 19. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
    Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, Zhang P, Xu L, Tan X, Chen J, Cheng S, Schaefer S, Cao G.
    Carcinogenesis; 2008 Sep 01; 29(9):1685-91. PubMed ID: 18192693
    [Abstract] [Full Text] [Related]

  • 20. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.
    Korean J Hepatol; 2008 Mar 01; 14(1):67-76. PubMed ID: 18367859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.